Filing Details
- Accession Number:
- 0001179110-13-002431
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-11 21:30:30
- Reporting Period:
- 2013-02-07
- Filing Date:
- 2013-02-11
- Accepted Time:
- 2013-02-11 21:30:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1225509 | M Suzanne Shema | C/O Onyx Pharmaceuticals, Inc. 249 E. Grand Ave. South San Francisco CA 94080 | Evp, Gc And Corp. Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-07 | 1,214 | $32.07 | 35,047 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-07 | 656 | $30.28 | 35,703 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-07 | 802 | $35.18 | 36,505 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-07 | 583 | $37.68 | 37,088 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-07 | 796 | $37.68 | 37,884 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-07 | 4,051 | $77.52 | 33,833 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-02-07 | 1,214 | $0.00 | 1,214 | $32.07 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-02-07 | 656 | $0.00 | 656 | $30.28 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-02-07 | 802 | $0.00 | 802 | $35.18 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-02-07 | 583 | $0.00 | 583 | $37.68 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-02-07 | 796 | $0.00 | 796 | $37.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,973 | 2019-08-31 | No | 4 | M | Direct | |
| 9,188 | 2020-03-31 | No | 4 | M | Direct | |
| 20,855 | 2021-03-31 | No | 4 | M | Direct | |
| 22,167 | 2022-03-29 | No | 4 | M | Direct | |
| 30,241 | 2022-03-29 | No | 4 | M | Direct |
Footnotes
- 25% of the shares subject to the option become exercisable one year following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 36 months for a total vesting schedule of 48 months.
- 12.5% of the shares subject to the option become exercisable 6 months following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months.
- The shares vest monthly from the date of grant at a rate of 1/48th per month.
- Shares sold pursuant to a 10b5-1 Plan.
Billionaire Hedge Funds
